4b,9b-dihydroxy-5-isopropyl-7-methyl-4b,5,6,7,8,9b-hexahydroindeno[1,2-b]indole-9,10-dione | 1158819-93-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 4b,9b-dihydroxy-5-isopropyl-7-methyl-4b,5,6,7,8,9b-hexahydroindeno[1,2-b]indole-9,10-dione
• CAS: 1158819-93-2
• 化学式: C₁₉H₂₁NO₄
• 分子量: 327.38
• InChiKey: YRLGMQKVNLQJSG-UHFFFAOYSA-N

物化性质

• 熔点：
  198.9 °C
• 沸点：
  497.4±45.0 °C(predicted)
• 密度：
  1.38±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.74
• 重原子数：
  24.0
• 可旋转键数：
  1.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  77.84
• 氢给体数：
  2.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  4b,9b-dihydroxy-5-isopropyl-7-methyl-4b,5,6,7,8,9b-hexahydroindeno[1,2-b]indole-9,10-dione 在 palladium 10% on activated carbon 、 N,N,N',N'-Tetraisopropylsulfinyldiamin 、 溶剂黄146 作用下， 以 二苯醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 26.0h， 生成 9-hydroxy-5-isopropyl-7-methyl-5H-indeno[1,2-b]indol-10-one
  参考文献：
  名称：

  Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2

  摘要：

  由于其环状的6-5-5-6成员环结构，吲哚吲哚烯引起了人类CK2 ATP竞争性抑制剂设计的极大兴趣。本研究中，我们制备了二十一种吲哚[1,2-b]吲哚衍生物，并对它们进行了体外人类CK2的测试。吲哚吲哚酮5a和5b对人类CK2的抑制作用分别为IC50值0.17和0.61 µM。吲哚[1,2-b]吲哚醌7a在亚微摩尔范围内亦显示出对CK2的抑制活性（IC50 = 0.43 µM）。此外，还评估了大量吲哚吲哚烯衍生物对细胞系3T3、WI-38、HEK293T和MEF的细胞毒性活性。

  DOI：

  10.3390/ph8020279
• 作为产物：
  描述：

  5-甲基环己烷-1,3-二酮 以 甲醇 、 甲苯 为溶剂， 反应 28.0h， 生成 4b,9b-dihydroxy-5-isopropyl-7-methyl-4b,5,6,7,8,9b-hexahydroindeno[1,2-b]indole-9,10-dione
  参考文献：
  名称：

  Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2

  摘要：

  由于其环状的6-5-5-6成员环结构，吲哚吲哚烯引起了人类CK2 ATP竞争性抑制剂设计的极大兴趣。本研究中，我们制备了二十一种吲哚[1,2-b]吲哚衍生物，并对它们进行了体外人类CK2的测试。吲哚吲哚酮5a和5b对人类CK2的抑制作用分别为IC50值0.17和0.61 µM。吲哚[1,2-b]吲哚醌7a在亚微摩尔范围内亦显示出对CK2的抑制活性（IC50 = 0.43 µM）。此外，还评估了大量吲哚吲哚烯衍生物对细胞系3T3、WI-38、HEK293T和MEF的细胞毒性活性。

  DOI：

  10.3390/ph8020279

文献信息

• Partially Saturated Indeno[1,2-<i>b</i>]indole Derivatives via Deoxygenation of Heterocyclic α-Hydroxy-<i>N</i>,<i>O</i>-hemiaminals
  作者：Hans-Jörg Hemmerling、Guido Reiss

  DOI：10.1055/s-0028-1087983

  日期：——

  A series of 3-aminocyclohex-2-enones were reacted with indane-1,2,3-trione monohydrate (ninhydrin) yielding 4b,9b-dihydroxyindeno[1,2-b]indoles that were deoxygenated to indeno[1,2-b]indoles.

  一系列3-氨基环己烯-2-酮与单水合的吡喃-1,2,3-三酮（呋喃啉）反应，生成4b,9b-二羟基吲哚[1,2-b]吲哚，其后经脱氧反应转化为吲哚[1,2-b]吲哚。
• QSAR Model of Indeno[1,2-b]indole Derivatives and Identification of N-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-b]furan-3-carboxamide as a Potent CK2 Inhibitor
  作者：Samer Haidar、Christelle Marminon、Dagmar Aichele、Abdelhamid Nacereddine、Wael Zeinyeh、Abdeslem Bouzina、Malika Berredjem、Laurent Ettouati、Zouhair Bouaziz、Marc Le Borgne、Joachim Jose

  DOI：10.3390/molecules25010097

  日期：——

  was used to predict the activity of 25 compounds with naphtho[2,3-b]furan-4,9-dione derivatives, which were previously predicted as CK2 inhibitors via a molecular modeling approach. The activities of four naphtho[2,3-b]furan-4,9-dione derivatives were determined in vitro and one of them (N-isopentyl-2-methyl-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide) turned out to inhibit CK2 with an IC50

  酪蛋白激酶 II (CK2) 是一种深入研究的酶，涉及不同的疾病，尤其是癌症。不同的支架被用来开发这种酶的抑制剂。在这里，我们报告了 20 种酚类、酮类和对醌类茚并 [1,2-b] 吲哚衍生物作为 CK2 抑制剂的合成和生物学评价。活性最强的化合物是 5-isopropyl-1-methyl-5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-dione 4h 和 1,3-dibromo-5-isopropyl-5， 6,7,8-四氢茚并[1,2-b]indole-9,10-dione 4w，IC50 值为0.11 µM。此外，还开发了基于茚并[1,2-b]吲哚结构的 QSAR 模型。该模型用于预测 25 种含有萘并[2,3-b]呋喃-4,9-二酮衍生物的化合物的活性，这些化合物之前通过分子建模方法被预测为 CK2 抑制剂。体外测定了四种萘并[2,3-b]呋喃-4
• Screening of indeno[1,2-<i>b</i>]indoloquinones by MALDI-MS: a new set of potential CDC25 phosphatase inhibitors brought to light
  作者：Faten Alchab、Estelle Sibille、Laurent Ettouati、Emilie Bana、Zouhair Bouaziz、Angélique Mularoni、Elodie Monniot、Denyse Bagrel、Joachim Jose、Marc Le Borgne、Patrick Chaimbault

  DOI：10.1080/14756366.2016.1201480

  日期：2016.11.3

  Quinones and quinones-like compounds are potential candidates for the inhibition of CDC25 phosphatases. The combination of MALDI-MS analyses and biological studies was used to develop a rapid screening of a targeted library of indeno[1,2-b]indoloquinone derivatives. The screening protocol using MALDI-TOFMS and MALDI-FTICRMS highlighted four new promising candidates. Biological investigations showed that only compounds 5c-f inhibited CDC25A and -C phosphatases, with IC50 values around the micromolar range. The direct use of a screening method based on MALDI-MS technology allowed achieving fast scaffold identification of a new class of potent inhibitors of CDC25 phosphatases. These four molecules appeared as novel molecules of a new class of CDC25 inhibitors. Assessment of 5c-e in an MRC5 proliferation assay provided an early indicator of toxicity to mammalian cells. Compound 5d seems the most promising hit for developing new CDC25 inhibitors.